Advances in NDDS: An expansive menu of choices in the management of pandemic
Department of Pharmaceutics, College of Pharmacy, Madurai Medical College, Madurai-20.
Affiliated to The Tamilnadu Dr. M. G. R. Medical University, Chennai-32, Tamilnadu, India.
Review
International Journal of Frontiers in Biology and Pharmacy Research, 2022, 02(02), 001–006.
Article DOI: 10.53294/ijfbpr.2022.2.2.0031
Publication history:
Received on 12 February 2022; revised on 27 March 2022; accepted on 29 March 2022
Abstract:
Novel Drug Delivery System (NDDS) is a novel approach to deliver the drug that addresses the limitations of the traditional drug delivery systems with enhanced patient care and site specific drug delivery. Besides several NDDS are currently used for treating Coronavirus disease (COVID-19), nanovaccines, liposomes and nanoparticles are gaining more interest towards research and manufacturing in pharmaceutical industry. COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. It has found its roots from China and has declared as a pandemic all over the world by World Health Organization (WHO). Till now, there is no ultimate cure for this outbreak. The recent developments in the domain of NDDS opened up numerous research exposures in the development of vaccines for the COVID-19. This review discusses the management of COVID-19 using NDDS like nanovaccines, the repurposing of the existing drugs using nanosystems, and the major market players of NDDS.
Keywords:
NDDS; COVID-19 variants; NeoCoV; Twindemic; Repurposing
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0